LABORATORY RESEARCH MACROD2 Overexpression Mediates Estrogen Independent Growth and Tamoxifen Resistance in Breast Cancers Researchers found MACROD2 is amplified and overexpressed in metastatic tamoxifen-resistant tumors. Transgene overexpression of MACROD2 in breast cancer cell lines results in tamoxifen resistance, whereas RNAi-mediated gene knock down reverses this phenotype. [Proc Natl Acad Sci USA] Abstract | Press Release A Positive Role of DBC1 in PEA3-Mediated Progression of Estrogen Receptor-Negative Breast Cancer Scientists report that deleted in breast cancer 1 (DBC1) functions as a coactivator for the oncogenic ETS transcription factor PEA3 to promote estrogen receptor (ER)-negative breast cancer progression. DBC1 depletion inhibited the tumorigenic properties of ER-negative breast cancer cells in vitro and in vivo. [Oncogene] Abstract Invasive Breast Carcinoma Cells from Patients Exhibit MenaINV– and Macrophage-Dependent Transendothelial Migration Scientists found that intravasation of breast cancer cells may be prevented by blocking the signaling between cancer cells and macrophages. They obtained invasive breast ductal carcinoma cells of various subtypes by fine-needle aspiration biopsies from patients and found that, in an in vitro transendothelial migration assay, cells that migrated through a layer of human endothelial cells were enriched for the transcript encoding MenaINV. [Sci Signal] Abstract | Press Release Combination Therapy Targeting Ectopic ATP Synthase and 26S Proteasome Induces ER Stress in Breast Cancer Cells Researchers investigated the anticancer effects of the ATP synthase inhibitor citreoviridin on breast cancer cells through proteomic approaches and revealed that differentially expressed proteins in cell cycle regulation and in the unfolded protein response were functionally enriched. [Cell Death Dis] Full Article Inhibition of SGK1 Enhances mAR-Induced Apoptosis in MCF-7 Breast Cancer Cells Testosterone albumin conjugates (TAC)-stimulated membrane androgen receptors (mAR) activation elicited apoptosis of MCF-7 cells, an effect significantly potentiated by concomitant incubation of the cells with TAC and the specific SGK1 inhibitors EMD638683 and GSK650394. [Cancer Biol Ther] Abstract Tumor Necrosis Factor-α Sensitizes Breast Cancer Cells to Natural Products with Proteasome-Inhibitory Activity Leading to Apoptosis Tumor necrosis factor-α, when combined with withaferin A or celastrol, activated caspase-3 and -9 and downregulated XIAP in a dose-dependent manner, leading to induction of apoptosis in MDA-MB-231 breast cancer cells. [PLoS One] Full Article The Cytotoxic Effect of the NOS-Mediated Oxidative Stress in MCF-7 Cells after PbCl2 Exposure Scientists show that PbCl2 treatment depresses the expressions of the three distinct nitric oxide synthase (NOS) isoforms: neuronal nitric oxide synthase, endothelial NOS, and inducible NOS on both transcriptional and translational levels in MCF-7 cells. [Environ Toxicol] Abstract Kisspeptin-10 Inhibits the Migration of Breast Cancer Cells by Regulating Epithelial-Mesenchymal Transition Researchers demonstrate the antitumor effects of kisspeptin-10 (KP-10) on human breast cancer cell lines, MDA-MB-231 and MDA-MB-157, both in vitro and in vivo. KP-10 was observed to induce apoptosis and inhibit the mobility of MDA-MB-231 and MDA-MB-157 cells. [Oncol Rep] Abstract Docetaxel Modulates the Delayed Rectifier Potassium Current (IK) and ATP-Sensitive Potassium Current (IKATP) in Human Breast Cancer Cells Scientists investigated the effects of docetaxel on the IK and the IKATP in two human breast cancer cell lines, MCF-7 and MDA-MB-435S, using the whole-cell patch-clamp technique. They show that docetaxel inhibited the IK and IKATP in both cell lines in a dose-dependent manner. [J Membr Biol] Abstract CLINICAL RESEARCH SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer Scientists determined the optimal dose and schedule of anthracycline and taxane administration as adjuvant therapy for early-stage breast cancer. [J Clin Oncol] Abstract Clinical Significance of SPRR1A Expression in Progesterone Receptor-Positive Breast Cancer Researchers focused on the expression of small proline-rich repeat protein 1A (SPRR1A) protein in breast cancers (BCs) in China. The relationship between SPRR1A expression and clinicopathological factors as well as BC prognoses was also determined. [Tumor Biol] Abstract |